Onderneming Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Aandelen
2315
CNE100005D27
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,89 CNY | +1,95% | -7,01% | -25,79% |
06/05 | Biocytogen sluit evaluatie- en potentiële licentieovereenkomst af met Biocopy voor TCR-imic antilichamen | CI |
26/04 | Verlies Biocytogen Pharmaceuticals kleiner in 2023 | MT |
Vakgebied
Aantal werknemers: 1 066
Verkoop per activiteit
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Animal Models Selling
38,1
%
| 197 | 31,7 % | 301 | 38,1 % | +53,09% |
Pre-clinical Pharmacology and Efficacy Evaluation
27,0
%
| 205 | 33,0 % | 214 | 27,0 % | +4,37% |
Antibody Development
24,5
%
| 148 | 23,8 % | 194 | 24,5 % | +31,70% |
Gene-editing
10,4
%
| 71 | 11,4 % | 82 | 10,4 % | +15,64% |
Others
0,1
%
| 1 | 0,1 % | 1 | 0,1 % | -6,07% |
Verkoop per regio
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
43,0
%
| 335 | 53,9 % | 341 | 43,0 % | +1,92% |
United States
42,0
%
| 208 | 33,5 % | 333 | 42,0 % | +59,88% |
Others
14,9
%
| 78 | 12,6 % | 118 | 14,9 % | +51,60% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yue Lei Shen
CEO | Chief Executive Officer | - | 13-11-09 |
Liu Bin
DFI | Director of Finance/CFO | - | 05-01-20 |
Sabrina Wang
COO | Chief Operating Officer | - | 01-10-19 |
Yi Yang
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-16 |
Jia Wei Yao
BRD | Director/Board Member | 41 | 01-06-12 |
Zhi Hong Li
PRN | Corporate Officer/Principal | - | 01-03-19 |
Chao She Guo
PRN | Corporate Officer/Principal | - | 01-10-13 |
Yan Zhu
HRO | Human Resources Officer | 60 | 01-12-11 |
Wai Ching Au
SEC | Corporate Secretary | - | - |
Yong Liang Wang
SEC | Corporate Secretary | 59 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yi Liang Wei
BRD | Director/Board Member | 53 | - |
Lei Di Zhang
BRD | Director/Board Member | 43 | 01-11-22 |
Ke Xiang Zhou
BRD | Director/Board Member | 60 | - |
Yue Lei Shen
CEO | Chief Executive Officer | - | 13-11-09 |
Jian Ni
BRD | Director/Board Member | - | - |
Hai Chao Zhang
BRD | Director/Board Member | - | - |
Yan Li
BRD | Director/Board Member | - | - |
Chang Yuan Yu
BRD | Director/Board Member | - | 01-12-20 |
Chun Li Sun
BRD | Director/Board Member | - | - |
44 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 288 616 500 | 0 | 0 | 16,99 % |
Aandeel B | 1 | 110 781 920 | 67 839 140 ( 61,24 %) | 0 |
Bedrijfsgegevens
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Room 1207, Building 3 88 Kechuang 6th Street
100176, Beijing
+86 10 5696 7680
http://www.bbctg.com.cnSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-25,79% | 454 mln. | |
+43,36% | 54,64 mld. | |
-5,31% | 39,92 mld. | |
+37,52% | 38,82 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+0,04% | 12,16 mld. | |
+25,12% | 12,21 mld. | |
+26,04% | 11,94 mld. |
- Beurs
- Aandelen
- Koers 2315
- Onderneming Biocytogen Pharmaceuticals (Beijing) Co., Ltd.